ETHK Labs Inc. (HKG:1931)
1.110
-0.010 (-0.89%)
At close: Mar 27, 2026
ETHK Labs Revenue
In the year 2025, ETHK Labs had annual revenue of 2.82B CNY, down -10.81%. ETHK Labs had revenue of 1.27B in the half year ending June 30, 2025, a decrease of -7.82%.
Revenue
2.82B CNY
Revenue Growth
-10.81%
P/S Ratio
0.57
Revenue / Employee
3.22M CNY
Employees
877
Market Cap
1.78B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.82B | -341.75M | -10.81% |
| Dec 31, 2024 | 3.16B | 74.03M | 2.40% |
| Dec 31, 2023 | 3.09B | 339.58M | 12.35% |
| Dec 31, 2022 | 2.75B | 18.14M | 0.66% |
| Dec 31, 2021 | 2.73B | 302.46M | 12.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 626.85B |
| Charmacy Pharmaceutical | 4.88B |
| Sipai Health Technology | 3.75B |
| Sinco Pharmaceuticals Holdings | 2.32B |
| ClouDr Group | 1.81B |
| 160 Health International | 725.41M |
| Ziyuanyuan Holdings Group | 575.61M |
| Wanjia Group Holdings | 163.70M |